These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3487815)

  • 21. [Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases].
    Martinka E; Shawkatová I; Straková J; Buc M; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):103-9. PubMed ID: 15641229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus.
    Boitard C; Bach JF
    Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326
    [No Abstract]   [Full Text] [Related]  

  • 24. Are the immune responses to endocrine autoantigens genetically restricted?
    Farid NR
    Autoimmunity; 1989; 3(1):47-55. PubMed ID: 2491619
    [No Abstract]   [Full Text] [Related]  

  • 25. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmunity in endocrine diseases.
    Rose NR; Burek CL
    Spec Top Endocrinol Metab; 1982; 4():139-76. PubMed ID: 6304927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors.
    Ito Y; Nieda M; Uchigata Y; Nishimura M; Tokunaga K; Kuwata S; Obata F; Tadokoro K; Hirata Y; Omori Y
    J Immunol; 1993 Nov; 151(10):5770-6. PubMed ID: 8228261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HLA histocompatibility system in autoimmune states.
    Braun WE; Zachary AA
    Clin Lab Med; 1988 Jun; 8(2):351-72. PubMed ID: 3284701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Autoimmunologic phenomena in endocrinopathies - relevance to medical practice].
    Scherbaum WA
    Med Welt; 1984 Feb; 35(7):199-203. PubMed ID: 6700431
    [No Abstract]   [Full Text] [Related]  

  • 31. Endocrine autoimmune diseases.
    Drexhage HA; Wulffraat NM
    Neth J Med; 1994 Dec; 45(6):285-93. PubMed ID: 7838245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The HLA system class II. Its implication in auto-immune endocrine diseases].
    Saï P; Houssaint E
    Ann Endocrinol (Paris); 1989; 50(3):237-45. PubMed ID: 2510577
    [No Abstract]   [Full Text] [Related]  

  • 36. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-endocrine interactions in autoimmune thyroid diseases.
    Klecha AJ; Barreiro Arcos ML; Frick L; Genaro AM; Cremaschi G
    Neuroimmunomodulation; 2008; 15(1):68-75. PubMed ID: 18667802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-cell damage in diabetic insulitis: are we approaching a solution?
    Bottazzo GF
    Diabetologia; 1984 Apr; 26(4):241-9. PubMed ID: 6376230
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autoimmune polyendocrinopathies. Pathogenic hypotheses].
    Scherbaum WA; Youinou P; Tater D; Jouquan J; Pujol-Borrell R; Bercovici JP; Bottazzo GF
    Ann Endocrinol (Paris); 1986; 47(6):420-8. PubMed ID: 3827197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of Ia-like antigens on T lymphocytes in lesions of psoriasis, lichen planus and discoid lupus erythematosus.
    Bjerke JR; Matre R
    Acta Derm Venereol; 1983; 63(2):103-7. PubMed ID: 6189323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.